Is Two-Dimensional Field Definition Sufficient for Pelvic Node Coverage in Rectal Cancer Compared to Technical Three-Dimensional Definition?

Background and aim To assess the effectiveness of the potential advantages with 3-dimensional-based treatment planning versus 2-dimensional pelvic bone-based treatment planning in patients with rectal cancer, controlled for clinical stage. Methods and materials Areas at risk from computed tomography in 30 patients were delineated: mesorectum, presacral, internal iliac, obturator and external iliac nodes. Two planning target volumes per patient were created: PTV_T3 (M + PSN + ON + IIN) and PTV_T4 (M + PSN + ON + IIN + EIN). Two- and 3–dimensional treatment plans for each planning target volume were calculated. Three analyses were performed: 1) mean volume receiving doses >95% and >105%; according to the percentage of prescribed dose to cover at least 95% of the planning target volume, the treatment plan was defined as optimal dose >95%, acceptable dose between 95% and 90%, inferior dose <90%; 2) comparison of the percentage of volume covered by the dose for 2- vs 3-dimensional; 3) determination of the doses at which the lack of volume coverage started to decrease significantly. Results For PTV_T3, the following was seen: 1) 2D vs 3D comparison showed optimal PTV_T3 coverage in 76.7% and 96.7%, respectively; 2) 2D vs 3D TP coverage difference was significant between 29%-95% of the total dose; 3) the lack of volume coverage started at 30% for 2D and 89% for 3D. For PTV_T4, the following was seen: 1) 2D vs 3D comparison showed an optimal PTV_T4 coverage in 33.3% and 86.7%, respectively; 2) 2D vs 3D TP coverage difference was significant between 7%-97% of the total dose; 3) the lack of volume coverage started at 7% for 2D and 87% for 3D. Conclusions The 3D treatment planning was superior to 2D treatment planning in covering areas at risk for pelvic recurrence in patients treated for rectal cancer. The areas with suboptimal coverage may lead to an increased risk of recurrence and should be correlated with the patterns of recurrence.

[1]  Jasper Nijkamp,et al.  Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  C. V. D. van de Velde,et al.  Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. , 2011, International journal of radiation oncology, biology, physics.

[3]  R. Glynne-Jones,et al.  Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer. , 2011, The British journal of radiology.

[4]  C. V. D. van de Velde,et al.  Origin of presacral local recurrence after rectal cancer treatment , 2010, The British journal of surgery.

[5]  C. Marijnen,et al.  Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Issam El Naqa,et al.  Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. , 2009, International journal of radiation oncology, biology, physics.

[7]  J. Monson,et al.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.

[8]  C. V. D. van de Velde,et al.  Patterns of Local Recurrence in Rectal Cancer: A Single-Center Experience , 2008, Annals of Surgical Oncology.

[9]  B. Glimelius,et al.  Local recurrence in rectal cancer: anatomic localization and effect on radiation target. , 2008, International journal of radiation oncology, biology, physics.

[10]  P. Bhosale,et al.  Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. , 2008, International journal of radiation oncology, biology, physics.

[11]  L. Murrer,et al.  Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Phil Quirke,et al.  What is the role for the circumferential margin in the modern treatment of rectal cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Karin Haustermans,et al.  IGRT in rectal cancer , 2008, Acta oncologica.

[14]  H. Putter,et al.  The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma , 2007, Annals of surgery.

[15]  Sung Ho Moon,et al.  Lateral Lymph Node Metastasis Is a Major Cause of Locoregional Recurrence in Rectal Cancer Treated with Preoperative Chemoradiotherapy and Curative Resection , 2007, Annals of Surgical Oncology.

[16]  H. Ueno,et al.  Potential Prognostic Benefit of Lateral Pelvic Node Dissection for Rectal Cancer Located Below the Peritoneal Reflection , 2007, Annals of surgery.

[17]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Bujko,et al.  Long‐term results of a randomized trial comparing preoperative short‐course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer , 2006, The British journal of surgery.

[19]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[20]  Karin Haustermans,et al.  Definition and delineation of the clinical target volume for rectal cancer. , 2006, International journal of radiation oncology, biology, physics.

[21]  R. Reznek,et al.  Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[22]  S. Arcangeli,et al.  Underlying anatomy for CTV contouring and lymphatic drainage in rectal cancer radiation therapy. , 2003, Rays.

[23]  C. Capirci,et al.  Dislocation of small bowel volume within box pelvic treatment fields, using new "up down table" device. , 2001, International journal of radiation oncology, biology, physics.

[24]  K. Sugihara,et al.  Importance of Extended Lymphadenectomy with Lateral Node Dissection for Advanced Lower Rectal Cancer , 1997, World Journal of Surgery.

[25]  J. Tepper,et al.  Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. , 1985, International journal of radiation oncology, biology, physics.